Funded Tech Companies
Akero Therapeutics
Headquartered in Cambridge, Akero Therapeutics raised its funding from BVF Partners, Boxer Capital and venBio.
Company Overview
Company Name
Akero Therapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
400 Technology Sq. 10th Floor
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Akero Therapeutics (Nasdaq: AKRO) is committed to providing meaningful treatment options for people with serious metabolic diseases like non-alcoholic steatohepatitis (NASH), a disease marked by inflammation in the liver and liver cell damage resulting in fibrosis, cirrhosis, liver failure and death.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/19/2019
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Andrew Cheng
Chief Operating Officer
Jonathan Young
Chief Scientific Officer
Timothy Rolph
VP - Bus. Development
Kitty Yale
Company Investors
- BVF Partners
- Boxer Capital
- venBio (Aaron Royston)
- Atlas Venture (Kevin Bitterman)
- Rock Springs Capital
- Versant Ventures (Graham Walmsley)
- Apple Tree Partners (Aaron Kantoff)
- LifeSci Venture Partners
- Cormorant Asset Management
- Redmile Group
- Janus Henderson Investors
Browse more funded tech companies:
Share this article
About Our VC Deals Database
The company data above is provided by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs